Dublin, Sept. 08, 2017 -- The "NGS, RNA-Seq, Single Cell Analysis & Single Molecule Analysis: Research to Diagnostics 2017" conference has been added to Research and Markets' offering.
Welcome to the Select Biosciences, Inc. NGS, RNA-Seq, Single Cell Analysis & Single Molecule Analysis: Research to Diagnostics 2017 Conference.
This conference brings together technology development and applications of:
- RNA-Seq
- Single Cell Analysis (SCA)
- Single Molecule Analysis (SMA)
It has become increasingly apparent that the differences between cells in the same population can be significant, and there is therefore a need for improved methods to capture and analyze individual cells such as circulating tumor cells (CTCs). The development of technologies for single cell analysis (SCA) is driving this field forward via basic research on isolated individual cells, the development of biomarker assays, and diagnostics development.
We also explore at this conference the translation of next-generation sequencing (NGS) from research to deployment in the clinical-setting for oncology, genetic testing, as well as infectious disease testing. In this vein, this conference explores technology development and applications of RNA-Seq -- an expanding segment within the broader NGS space. This conference will also present the latest technologies/products in flow cytometry and FISH.
Agenda:
- Flow Cytometry, FISH and Technologies for Single Cell Analysis (SCA)
- Front-end Sample Preparation for NGS and RNA-Seq: Challenges with Clinical Samples
- Microfluidics-based Devices for Single Cell Analysis (SCA)
- NGS on Rare Cells (such as Circulating Tumor Cells) and for Clinical Applications
- RNA-Seq for Transcriptional Characterization and Profiling
- Single Cell Analysis (SCA) and Single Molecule Analysis (SMA) for Diagnostics Development and Genetic, Prenatal Testing
- Single Cell Analysis (SCA) and Single Molecule Analysis (SMA) in Cancer, CNS Diseases, and Other Disease Classes
Speakers
- Lydia Sohn, Professor, Department of Mechanical Engineering, University of California, Berkeley
- Lidong Qin, Professor, CPRIT Scholar, Houston Methodist Research Institute
- Paul Bohn, Arthur J. Schmitt Professor of Chemical and Biomolecular Engineering and Professor of Chemistry and Biochemistry, University of Notre Dame
- Sheng Zhong, Professor, University of California-San Diego
- Roger Lasken, Director of Single Cell Genomics, J. Craig Venter Institute
- Gary Schroth, Vice President and Distinguished Scientist, Illumina
- Sarah Munro, Team Leader, Genome-Scale Measurements Group, Joint Initiative for Metrology in Biology, National Institute of Standards and Technology (NIST)
- Abraham Lee, William J. Link Professor and Chair, University of California-Irvine
- Yu-Hwa Lo, Professor, University of California San Diego
- John Nolan, Professor, The Scintillon Institute
- Joseph Blattman, Assistant Professor, School of Life Sciences and The Biodesign Institute, Arizona State University
- Stphane Boutet, Staff Scientist, 10x Genomics
- Ye Chen-Izu, Associate Professor, Department of Biomedical Engineering, University of California-Davis
- Naiwen Cui, Researcher, David Weitz Research Group, School of Engineering and Applied Science, Harvard University
- Ann Feeney, Professor, The Scripps Research Institute
- Anna Gerdtsson, Research Scientist, The Bridge Institute, University of Southern California
- Kalyan Handique, CEO & President, Celsee Diagnostics
- Nathan Lewis, Assistant Professor, Department of Pediatrics, University of California-San Diego
- Sara Linker, Research Fellow, The Salk Institute for Biological Studies
- Dan Lucking, Director, Molecular Machines & Industries (MMI)
- Holger Schmidt, Narinder Kapany Professor of Electrical Engineering, University of California-Santa Cruz
- Timothy K. Starr, Assistant Professor, University of Minnesota
- Guilhem Tourniaire, Scientific and Managing Director, Cellenion SASU
- Tania Vu, Associate Professor, Oregon Health and Science University
- Wei Wei, Assistant Professor, Department of Molecular and Medical Pharmacology, UCLA David Geffen School of Medicine
- Bart Westendorp, Assistant Professor, Department of Pathobiology, Utrecht University The Netherlands
- Zhibo Yang, Assistant Professor, University of Oklahoma Health Sciences Center
- Guang Yao, Assistant Professor, Molecular/Cellular Biology, University of Arizona
- Jiang Zhong, Assistant Professor, University of Southern California
For more information about this conference visit https://www.researchandmarkets.com/research/chqrms/ngs_rnaseq
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Genomics, Diagnostics, Molecular Diagnostics


Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 



